Clinical and Translational Oncology Program (CTOP)

Oncologist in a lab with a microscope and test tubes

CTOP Specific Aims

  • Engineer and translate novel cellular therapies to elicit robust and potent anti-tumor responses against adult and pediatric cancers
  • Discover and repurpose molecular therapies that overcome identified mechanisms of resistance in refractory and/or relapsed cancers
  • Design technologies for diagnosis, early detection, and monitoring response to therapy
CTOP Specific Aims

CTOP Future Directions

  • Foster more interdisciplinary partnerships across CTOP aims to drive innovation, improve research outcomes, and maximize shared resource utilization
  • Increase multi-principal investigator grants by fostering interdisciplinary partnerships with CBIP and CCHE members and improving grant application support
  • Encourage and support researchers to develop and conduct more Investigator-Initiated Trials (IITs), enhancing the GW Cancer Center’s clinical research portfolio with an emphasis on catchment-responsive trials
  • Develop a K-like scholar program to support junior faculty in developing translational research careers

Program Leaders

Pavani Chalasani, MD, MPH

Program Leader

Pavani Chalasani, MD, MPH

Rohan Fernandes, PhD

Program Leader

Rohan Fernandes, PhD
 

Catherine Bollard

Associate Center Director
Translational Science and Innovation

Catherine Bollard, MD